These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. May M; Helke C; Nitzke T; Vogler H; Hoschke B Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349 [TBL] [Abstract][Full Text] [Related]
30. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer. Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396 [TBL] [Abstract][Full Text] [Related]
31. Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer. Lian F; Chen W; Liu Y; Shen L; Fan W; Cui W; Zhao Y; Li J; Wang Y J Cancer Res Clin Oncol; 2019 Jun; 145(6):1625-1633. PubMed ID: 30900154 [TBL] [Abstract][Full Text] [Related]
34. Radiotherapy is an effective treatment for high-risk T1-bladder cancer. Rödel C; Dunst J; Grabenbauer GG; Kühn R; Papadopoulos T; Schrott KM; Sauer R Strahlenther Onkol; 2001 Feb; 177(2):82-8; discussion 89. PubMed ID: 11233839 [TBL] [Abstract][Full Text] [Related]
35. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Kaufman DS; Winter KA; Shipley WU; Heney NM; Chetner MP; Souhami L; Zlotecki RA; Sause WT; True LD Oncologist; 2000; 5(6):471-6. PubMed ID: 11110598 [TBL] [Abstract][Full Text] [Related]
36. Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy. Mori K; Nomata K; Noguchi M; Eguchi J; Hayashi N; Kanetake H Int J Urol; 2007 Jul; 14(7):591-4. PubMed ID: 17645599 [TBL] [Abstract][Full Text] [Related]
37. Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease? Tachibana I; Bandali E; Calaway AC; Krishnan N; Cheng L; Adra N; Kaimakliotis HZ Urol Oncol; 2020 Nov; 38(11):850.e1-850.e7. PubMed ID: 32693973 [TBL] [Abstract][Full Text] [Related]
38. Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer. Eapen L; Stewart D; Collins J; Peterson R J Urol; 2004 Oct; 172(4 Pt 1):1276-80. PubMed ID: 15371823 [TBL] [Abstract][Full Text] [Related]
39. The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer. Liu Z; Ye Y; Li X; Guo S; Jiang L; Dong P; Li Y; Shi Y; Fan W; Cao Y; Yao K; Qin Z; Han H; Zhou F; Liu Z World J Urol; 2018 Aug; 36(8):1191-1200. PubMed ID: 29459997 [TBL] [Abstract][Full Text] [Related]
40. [Neoadjuvant intra-arterial chemotherapy followed by partial cystectomy for invasive bladder cancer]. Sekine H; Mine M; Ohya K; Kaneoya F; Yokokawa M Hinyokika Kiyo; 1992 Feb; 38(2):155-9. PubMed ID: 1561948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]